Search Results - marcus+seldin

1 Results

Sort By:

Novel Protein Therapeutic for Diabetes and Obesity

Novelty: This technology identifies a novel myonectin protein, which links skeletal muscle to metabolic regulation. Myonectin was found to lower circulating free fatty acid levels by promoting lipid uptake. Value Proposition: Type-2 diabetes, obesity, and metabolic syndrome are diseases that dramatically reduce patient quality of life and lead...

Published: 3/13/2025 | Inventor(s): Marcus Seldin, Guang Wong

Keywords(s): Biomarker, Diabetes, Disease Indication, Mechanism-of-action Biomarker, Metabolic Disorders, Obesity, Therapeutic Matter, Therapeutics, Type II Diabetes

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Metabolic Diseases, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Metabolic Diseases > Obesity, Clinical and Disease Specializations > Diabetes > Type 2 Diabetes